文献速递中毒与环境急症重症综合管理与镇静镇痛

高压氧治疗敌草快所致中毒性脑损伤亚急性或慢性期:三例回顾性分析

Hyperbaric oxygen therapy for diquat-induced toxic brain injury in the subacute or chronic phase.
PubMed 文献 · Clin Toxicol (Phila) · 2025-11-11
一句话结论3例敌草快中毒性脑损伤患者在亚急性或慢性期接受高压氧治疗后影像病灶缩小、2例神经功能与日常活动能力改善,但样本小且无对照,作者认为需更大前瞻性研究验证。

该回顾性分析纳入3例因摄入敌草快溶液(20 g/L)后出现中毒性脑损伤的年轻成人,均曾发生短暂多器官功能障碍并接受支持治疗,表现为意识改变(嗜睡或昏迷)、颅内压升高及影像学中枢神经系统病灶。在生命体征与氧合稳定后给予高压氧治疗,治疗后神经影像显示病灶缩小;末次随访时2例神经功能评分与改良Barthel指数改善并达到临床独立,第3例因经济原因中断治疗。作者认为这些初步观察提示高压氧可能与亚急性或慢性期神经功能改善相关,可能机制包括改善组织氧合与调节炎症反应,但因样本量有限且缺乏对照组,需更大规模前瞻性研究验证疗效与安全性。

要点

  • 3例年轻成人摄入敌草快溶液(20 g/L)后出现中毒性脑损伤,表现为意识改变(嗜睡或昏迷)、颅内压升高及影像学中枢神经系统病灶。
  • 所有患者在生命体征与氧合稳定后接受高压氧治疗,治疗后神经影像显示病灶缩小。
  • 末次随访时2例神经功能评分与改良Barthel指数改善并达到临床独立,第3例因经济原因中断治疗。
  • 作者认为这些初步发现提示高压氧在亚急性或慢性期可能有获益,但样本量有限且无对照组,需更大前瞻性研究验证疗效与安全性。

适用人群与场景

  • 3例因摄入敌草快溶液(20 g/L)后发生中毒性脑损伤的年轻成人,处于亚急性或慢性期并接受高压氧治疗。
  • 所有患者均曾出现短暂多器官功能障碍并接受支持治疗,在生命体征与氧合稳定后开始高压氧治疗。

处置流程与药物剂量

  • 先以支持治疗处理短暂多器官功能障碍,待生命体征与氧合稳定后给予高压氧治疗。
  • 高压氧治疗的具体方案(压力、时长、频次、疗程)原文未写明。

研究设计与关键结果

  • 回顾性分析3例敌草快中毒性脑损伤患者,均表现为意识改变(嗜睡或昏迷)、颅内压升高及影像学中枢神经系统病灶。
  • 高压氧治疗后神经影像显示病灶缩小;末次随访时2例神经功能评分与改良Barthel指数改善并达到临床独立,第3例因经济原因中断治疗。

证据类型、等级与局限

  • 证据类型:回顾性病例分析(3例),无对照组。
  • 局限:样本量有限且缺乏对照组,需更大规模前瞻性研究验证疗效与安全性。

对床旁实践的改变

  • 作者认为,这些初步发现提示高压氧在敌草快所致中毒性脑损伤亚急性或慢性期可能有获益,可能机制包括改善组织氧合与调节炎症反应。
  • 作者指出,因样本量有限且缺乏对照组,需更大规模前瞻性研究验证其疗效与安全性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Diquat-induced toxic brain injury is a challenging clinical issue, characterized by oxidative stress and neuroinflammation, which causes extensive damage to the central nervous system and has a poor prognosis.

METHODS: We conducted a retrospective analysis of three patients diagnosed with diquat-induced toxic brain injury who underwent hyperbaric oxygen therapy in the subacute or chronic phase. Clinical data, laboratory findings, and neuroimaging were reviewed to assess their response to treatment.

RESULTS: Three young adults were admitted following ingestion of diquat solution (20 g/L) and developed transient multiorgan dysfunction, managed with supportive interventions. All patients exhibited altered consciousness, such as somnolence or coma, elevated intracranial pressure, and central nervous system lesions on imaging. After stabilization of vital signs and oxygenation, hyperbaric oxygen therapy was administered. Post-treatment neuroimaging demonstrated lesion reduction. At final follow-up, two patients showed improvements in their Neurofunctional Scores and modified Barthel Indices, achieving clinical independence, while the third patient discontinued treatment for financial reasons.

DISCUSSION: These observations suggest a potential association between hyperbaric oxygen therapy and neurological improvement in the subacute or chronic phase of diquat-induced toxic brain injury. Possible underlying mechanisms may include improved tissue oxygenation and modulation of inflammatory responses.

CONCLUSIONS: These preliminary findings suggest a possible benefit of hyperbaric oxygen therapy in the subacute or chronic phase of diquat-induced toxic brain injury. However, due to the limited sample size and lack of a control group, larger and prospective studies are needed to verify its efficacy and safety.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Wang P, Luo CF, Li T, et al. Hyperbaric oxygen therapy for diquat-induced toxic brain injury in the subacute or chronic phase. Clin Toxicol (Phila). 2025. PMID: 41217203. doi:10.1080/15563650.2025.2557434

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。